跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
NMPA
/
Salbutamol Sulfate Inhalation Solution
Approved
化学药品
Salbutamol Sulfate Inhalation Solution
Glaxosmithkline Australia Pty Ltd.
🇨🇳 National Medical Products Administration
Approval Date
Nov 2, 2021
Approval ID
8CYnvtOIOQf
Company
Glaxosmithkline Australia Pty Ltd.
Type
化学药品
Approval Details
Approval Id
8CYnvtOIOQf
Approval Number
国药准字HJ20160660
Generic Name
吸入用硫酸沙丁胺醇溶液
Generic Name En
Salbutamol Sulfate Inhalation Solution
Trade Name
万托林
Brand Name
万托林
Drug Type
化学药品
Dosage Form
吸入溶液剂
Strength
2.5ml:5mg(以沙丁胺醇计)
Reg Date
2021-11-02
Expired Date
2026-11-01
Company Name
Glaxosmithkline Australia Pty Ltd.
Company Address
1061 Mountain Highway BORONIA VIC 3155 Australia
Production Company Name
Glaxosmithkline Australia Pty Ltd.
Production Company Address
1061 Mountain Highway BORONIA VIC 3155 Australia
Company Detail Path
/organization/glaxosmithkline-australia-pty-ltd-australia
Production Company Detail Path
/organization/glaxosmithkline-australia-pty-ltd-australia
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Nov 2, 2021
Approval ID
8CYnvtOIOQf
Type
化学药品
Back to NMPA Approvals
万托林 - NMPA Drug Approval Details